Loretta Cangialosi is a Certified Public Accountant with over 30 years of experience and is currently Senior Vice President and Controller of Pfizer Inc.
In February of 1993, Ms. Cangialosi joined Pfizer Inc. holding various positions of increasing responsibility in the Controllers Division. In October 1999, Ms. Cangialosi was named Vice President and elected as Controller. As such, she oversees accounting guidance, policies and training, external and internal financial reporting, consolidations, internal controls and lends her expertise to various business development activities and transformational projects. She has overseen three major acquisitions and subsequent integration efforts into Pfizer.
She is a member of many leadership, sponsor and steering committee groups within Pfizer and is actively involved in providing strategic direction for Finance, information technology systems, compliance activities, and business development activities. She ensures Pfizerís voice is included in the shaping of new accounting and reporting standards and regulations including meeting with the Office of the Chief Accountant of the Securities and Exchange Commission as well as members of the Financial Accounting Standards Board and International Accounting Standards Board.
Prior to joining Pfizer, Ms. Cangialosi was a Senior Manager with KPMG in its New York Audit Group.
Ms. Cangialosi currently serves on the Executive Committee of the Financial Executives International Committee on Corporate Reporting and serves on the Public Company Accounting Oversight Boardís Standing Advisory Group which advises that Board on auditing standards and independent auditor topics.
In 2013, she was elected to the Adelphi University Board of Trustees. A generous benefactor of the University, she has established the Loretta Cangialosi Endowed Scholarship, which provides financial support to Adelphi students who demonstrate financial need.